| Term 
 | Definition 
 
        | insulin   ultra short acting     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | insulin short acting   only form that can be used IV |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | insulin   long acting   precipitates at physio pH |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | sulfonylurea   insulin secretogogue   4-5 hours liver |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sulfonylurea   insulin secretagogue   32 hrs liver |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sulfonylurea   insulin secretagogue   7hr |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sulfonylurea   insulin secretagogue   2nd gen |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sulfonylurea   insulin secretagogue   2-4 hrs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sulfonylurea   insulin secretagogue   5 hrs 1 a day |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | meglitinides   insulin secretagogue     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | insulin sensitizer   biguanides     |  | 
        |  | 
        
        | Term 
 
        | pioglitazone   rosiglitazone |  | Definition 
 
        | insulin sensitizer     PPARy nuclear receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | insulin sensitizer   alpha-glucosidase inhibitor   prevents starch breakdown in gi |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | insulin sensitizer   alpha-glucosidase inhibitor   prevents  starch breakdown in gi |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | fsh   post menopausal women's urine |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | acts as LH   increase testosterone in Leydig cell increase ovulation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | estrogen replacement   increase bone mass   risk of breast cancer   transdermal patch   give progestin to protect endometium |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | estrogen   from pregger mare     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | estrogen   very potent   synthetic   vaginal tumors in offspring |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antifibrolytic   used after surgery or heavy period   decreases plasmin activation |  | 
        |  | 
        
        | Term 
 
        | toremifene   tamoxifene   raloxifene |  | Definition 
 
        | anti estrogen   SERM   competes with estrogen   estrogenic in breast   anti estrogenic in bone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti estrogen   weak agonist   int. antagonist   fertility drug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti estrogen   ER inhibitor   treats estrogen dependent breast cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | ru486   anti progestin   abortive |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti androgen   treats hirsuitism |  | 
        |  | 
        
        | Term 
 
        | flutamide   bicalutamide   nilutamide |  | Definition 
 
        | anti adrogen   receptor inhibitor   treat prostate cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 5alpha reductase competative inhibitor   male pattern baldness, bph |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pth   expensive   osteoperosis |  | 
        |  | 
        
        | Term 
 
        | aledronate   risedronate   etidronate   zoledronate   ibandronate |  | Definition 
 
        | biphosphonates   decrease osteoclast activity   z=iv     |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | dmard   cross links dna   chemo drug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dmard   inhibits calcineurin   reduces il2   sever ra w/ methotrexate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dmard   inactivates t cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits release of cytokines   dmard |  | 
        |  | 
        
        | Term 
 
        | chloroquinine   hydroxychloroquinine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | adalimumab   infliximab   etanercept |  | Definition 
 | 
        |  |